Efficacy of different vasodilators on human umbilical arterial smooth muscle under normal and reduced oxygen conditions

Early Human Development

Volumn 82, Issue 7, 2006, Pages 457-462

  Leung, Susan W S ^a   Quan, Adrian ^a,b   Lao, Terence T ^a   Man, Ricky Y K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Calcium channel antagonist; Human umbilical arteries; Nitric oxide; Potassium channel opener; Vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; LEMAKALIM; NITROGEN; NITROPRUSSIDE SODIUM; OXYGEN; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; SEROTONIN; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; VASODILATOR AGENT;

ARTERY MUSCLE; ARTICLE; BLOOD VESSEL REACTIVITY; CESAREAN SECTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOXIA; SMOOTH MUSCLE; UMBILICAL ARTERY; UREA CYCLE; VASOCONSTRICTION; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AMLODIPINE; ANOXIA; CROMAKALIM; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; POTASSIUM CHLORIDE; SEROTONIN; THROMBOXANE A2; UMBILICAL ARTERIES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33745495055     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2005.11.009     Document Type: Article

References (23)

1. Fleischer A., Schulman H., Farmakides G., Bracero L., Blattner P., and Randolph G. Umbilical artery velocity waveforms and intrauterine growth retardation. Am J Obstet Gynecol 151 (1985) 502-505
2. Makino Y., Izumi H., Makino I., and Shirakawa K. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 73 (1997) 139-143
3. Pinto A., Sorrentino R., Sorrentino P., Guerribore T., Miranda L., Biondi A., et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 164 (1991) 507-513
4. Stuart M.J., Clark D.A., Sunderji S.G., Allen J.B., Yambo T., Elrad H., et al. Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet 1 (1981) 1126-1128
5. Dadak C., Kefalides A., Sinzinger H., and Weber G. Reduced umbilical artery prostacyclin formation in complicated pregnancies. Am J Obstet Gynecol 144 (1982) 792-795
6. Bertrand C., Duperron L., and St-Louis J. Umbilical and placental vessels: modifications of their mechanical properties in preeclampsia. Am J Obstet Gynecol 168 (1993) 1537-1546
7. White R.P. Comparison of vasorelaxants in human basilar arteries and umbilical arteries. Eur J Pharmacol 155 (1988) 109-115
8. Renowden S., Edwards D.H., and Griffith T.M. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth. Br J Pharmacol 106 (1992) 348-353
9. Xie H., and Triggle C.R. Endothelium-independent relaxations to acetylcholine and A23187 in the human umbilical artery. J Vasc Res 31 (1994) 92-105
10. Belfort M.A., Saade G.R., Suresh M., Johnson D., and Vedernikov Y.P. Human umbilical vessels: responses to agents frequently used in obstetric patients. Am J Obstet Gynecol 172 (1995) 1395-1403
11. van de Voorde J., Vanderstichele H., and Leusen I. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 60 (1987) 517-522
12. Chaudhuri G., Buga G.M., Gold M.E., Wood K.S., and Ignarro L.J. Characterization and actions of human umbilical endothelium derived relaxing factor. Br J Pharmacol 102 (1991) 331-336
13. Sexton A.J., Loesch A., Turmaine M., Miah S., and Burnstock G. Nitric oxide and human umbilical vessels: pharmacological and immunohistochemical studies. Placenta 16 (1995) 277-288
14. Bodelsson G., and Stjernquist M. Endothelium-dependent relaxation to substance P in human umbilical artery is mediated via prostanoid synthesis. Human Reprod 9 (1994) 733-737
15. Izumi H., Garfield R.E., Makino Y., Shirakawa K., and Itoh T. Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery. Am J Obstet Gynecol 170 (1994) 236-245
16. Erskine R.L.A., and Ritchie J.W.K. Umbilical artery blood flow characteristics in normal and growth-retarded fetuses. Br J Obstet Gynaecol 92 (1987) 605-610
17. Akar F., Ark M., Uydes B.S., Soysal M.E., Saracoglu F., Abacioglu N., et al. Nitric oxide production by human umbilical vessels in severe pre-eclampsia. J Hypertens 12 (1994) 1235-1241
18. Ranta V., Viinikka L., Halmesmaki E., and Ylikorkala O. Nitric oxide production with preeclampsia. Obstet Gynecol 93 (1999) 442-445
19. Amit A., Thaler I., Paz Y., and Itskovitz-Eldor J. The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy. Ultrasound Obstet Gynecol 11 (1998) 94-98
20. Eltherington L.G., Stoff J., Hughes T., and Melmon K.L. Constriction of human umbilical arteries: interaction between oxygen and bradykinin. Circ Res 22 (1968) 747-752
21. McGrath J.C., MacLennan S.J., and Whittle M.J. Comparison of the effects of oxygen, 5-hydroxytryptamine, bradykinin and adrenaline in isolated human umbilical artery smooth muscle. Q J Exp Physiol 73 (1988) 547-559
22. Bodelsson G., Laursen M., and Stjernquist M. Oxygen promotes contraction by endothelin-1 in human umbilical artery. Human Reprod 11 (1996) 2767-2768
23. 2 as physiologic mediators of human umbilical artery closure. J Soc Gynecol Investig 10 (2003) 490-495